The Clinical Manifestations and Treatment of Male Breast Cancer: a Report of Three Cases

Overview

Journal Surg Case Rep

Specialty General Surgery

Date 2016 Mar 5

PMID 26943416

Authors

Shuji Suehiro

Miyuki Abe

Yohei Takumi

Takafumi Hashimoto

Mirei Kamei

Atsushi Osoegawa

Michiyo Miyawaki

Kenji Sugio

Affiliations

Soon will be listed here.

Abstract

Male breast cancer is an extremely rare malignancy. We treated three male breast cancer patients. All three patients showed clinical N0 and received sentinel lymph node biopsy. Because the sentinel lymph node was positive for metastasis in one patient, a total mastectomy with axillary lymph node dissection was performed. The other two patients were negative for sentinel lymph node metastasis, and a simple mastectomy was performed. Two of the patients were postoperatively treated with tamoxifen; another patient was treated with adjuvant chemotherapy using taxotere and cyclophosphamide before tamoxifen. There was no recurrence in any of the three patients during an average follow-up period of 56.7 months (range 11.8-80.3). A sentinel lymph node biopsy is recommended for node staging in both male and female breast cancer patients as it is associated with a lower incidence of complications.

References

Cutuli B, Lacroze M, Dilhuydy J, Velten M, de Lafontan B, Marchal C . Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995; 31A(12):1960-4. DOI: 10.1016/0959-8049(95)00366-5. View

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View

Muir D, Kanthan R, Kanthan S . Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med. 2003; 127(1):36-41. DOI: 10.5858/2003-127-36-MVFB. View

JOCHIMSEN P, Menck H, Winchester D . An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999; 126(4):775-80; discussion 780-1. View

Nahleh Z, Srikantiah R, Safa M, Jazieh A, Muhleman A, Komrokji R . Male breast cancer in the veterans affairs population: a comparative analysis. Cancer. 2007; 109(8):1471-7. DOI: 10.1002/cncr.22589. View

Petrek J, Blackwood M . Axillary dissection: current practice and technique. Curr Probl Surg. 1995; 32(4):257-323. DOI: 10.1016/s0011-3840(05)80015-2. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

Overgaard M, Nielsen H, Overgaard J . Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007; 82(3):247-53. DOI: 10.1016/j.radonc.2007.02.001. View

Giordano S, Cohen D, Buzdar A, Perkins G, Hortobagyi G . Breast carcinoma in men: a population-based study. Cancer. 2004; 101(1):51-7. DOI: 10.1002/cncr.20312. View

10.

Lyman G, Giuliano A, Somerfield M, Benson 3rd A, Bodurka D, Burstein H . American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23(30):7703-20. DOI: 10.1200/JCO.2005.08.001. View

11.

Bloom K, Govil H, Gattuso P, Reddy V, Francescatti D . Status of HER-2 in male and female breast carcinoma. Am J Surg. 2001; 182(4):389-92. DOI: 10.1016/s0002-9610(01)00733-4. View

12.

Pemmaraju N, Munsell M, Hortobagyi G, Giordano S . Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol. 2011; 23(6):1471-4. PMC: 3493137. DOI: 10.1093/annonc/mdr459. View

13.

Flynn L, Park J, Patil S, Cody 3rd H, Port E . Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008; 206(4):616-21. DOI: 10.1016/j.jamcollsurg.2007.11.005. View

14.

Ashikaga T, Krag D, Land S, Julian T, Anderson S, Brown A . Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010; 102(2):111-8. PMC: 3072246. DOI: 10.1002/jso.21535. View

15.

Fentiman I, Fourquet A, Hortobagyi G . Male breast cancer. Lancet. 2006; 367(9510):595-604. DOI: 10.1016/S0140-6736(06)68226-3. View

16.

Rudlowski C, Friedrichs N, Faridi A, Fuzesi L, Moll R, Bastert G . Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat. 2004; 84(3):215-23. DOI: 10.1023/B:BREA.0000019953.92921.7e. View